Skip to main content
Clinical Trials/NCT05216692
NCT05216692
Completed
Not Applicable

Effects of a Foot Strengthening Protocol on Foot Strength, Foot Morphological Deformation and Kinetics Parameters : a Monocentric Randomized Controlled Trial

François Fourchet1 site in 1 country28 target enrollmentJanuary 3, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Foot Strength Deficit
Sponsor
François Fourchet
Enrollment
28
Locations
1
Primary Endpoint
Change in Hallux flexion strength
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The principal aim of this study is to investigate the effects of a four-week foot strenghtening protocol combining active voluntary exercises and assisted-active voluntary exercises by neuromuscular electrical stimulation on hallux toe flexion strength in comparison to a standard foot strengthening protocol in a healthy adult recreational active population.

The secondary objectives of the study are to investigate the effects of this protocol on lesser toes flexor strength, foot morphology deformation in one, two and three dimensions and kinetic parameters when walking and running.

Registry
clinicaltrials.gov
Start Date
January 3, 2022
End Date
February 11, 2022
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
François Fourchet
Responsible Party
Sponsor Investigator
Principal Investigator

François Fourchet

PhD, Physiotherapist. Head of physiotherapy and ergotherapy.

La Tour Hospital

Eligibility Criteria

Inclusion Criteria

  • Level of weekly physical activity (recreational activity and regular non-competitive runners : at least 1 running session per week)

Exclusion Criteria

  • History of pain or episodes of foot or ankle sprains during the past 6 months;
  • Foot or leg fractures during the past year;
  • Severe deformity of the foot or leg;
  • Self-declared disability due to neuromuscular impairment of the lower limbs;
  • Neurological or vestibular deficit that could hinder balance (diabetes mellitus, radiculopathie lumbosacral, soft tissue disorder such as Marfan or Ehlers-Danlos syndrome) ;
  • Any absolute contraindication to neuromuscular electrical stimulation (NMES) (cardiac pacemaker, epileptic disorders, pregnancy defibrillator);
  • Participation in an exercise program specifically designed to strengthen the ankle or foot during the last 6 months

Outcomes

Primary Outcomes

Change in Hallux flexion strength

Time Frame: All measures will be collected on both feet 1 week prior the treatment and 1 week after the last intervention session

Hallux flexion strength will be assessed by a MicroFET2 Handheld Digital Dynamometer in hook lying position. The strength will be normalized by bodyweight (N/kg).

Secondary Outcomes

  • Change in Lesser toe flexion strength(All measures will be collected on both feet 1 week prior the treatment and 1 week after the last intervention session)
  • Change in Running and walking kinetics : Stiffness parameter(All measures will be collected on both feet 1 week prior the treatment and 1 week after the last intervention session)
  • Change in Running and walking kinetics : Pressure parameter(All measures will be collected on both feet 1 week prior the treatment and 1 week after the last intervention session)
  • Change in Running and walking kinetics : Time parameters(All measures will be collected on both feet 1 week prior the treatment and 1 week after the last intervention session)
  • Change in Foot morphological deformation(All measures will be collected on both feet 1 week prior the treatment and 1 week after the last intervention session)
  • Change in Running and walking kinetics : Force parameters(All measures will be collected on both feet 1 week prior the treatment and 1 week after the last intervention session)
  • Change in Running and walking kinetics : Distance parameters(All measures will be collected on both feet 1 week prior the treatment and 1 week after the last intervention session)
  • Change in Running and walking kinetics : Frequency parameter(All measures will be collected on both feet 1 week prior the treatment and 1 week after the last intervention session)

Study Sites (1)

Loading locations...

Similar Trials